Anzeige
Mehr »
Montag, 07.07.2025 - Börsentäglich über 12.000 News
Surfen Sie die heißeste Edelmetall-Welle des Jahrzehnts! Dieses TOP-Unternehmen zündet nächste Wachstumsstufe!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
398 Leser
Artikel bewerten:
(1)

Telemis Group Announces Acquisition of Germany-based ITZ Medicom GmbH & Co. KG

Strategic move gives Telemis a significant presence in the German market and an enhanced product and service offering

LOUVAIN-LA-NEUVE, Belgium, Nov. 12, 2019 /PRNewswire/ -- Telemis, the medical imaging, archiving and transmission specialist, has further strengthened its position in Europe as a leader in medical imaging management solutions with the acquisition of ITZ Medicom GmbH & Co. KG. The combined entity will have revenues of approximately €10M and be able to address 70% of the healthcare market in the Euro-zone.

Telemis strengthens its global product portfolio with the acquisition of ITZ Medicom (PRNewsfoto/Telemis)

Based in Willich, near Dusseldorf, ITZ Medicom has specialized in medical imaging management since 1997 and during that time become recognised as one of Germany's leading PACS (Picture Archiving and Communication System) and Telemedicine solution providers.

As a result of the acquisition, the Telemis Group will have a significantly strengthened global product portfolio that will include PACS and MACS (Multimedia Archiving and Communication System), Telemedicine, Digital Pathology and Healthcare cockpit solutions that will now be offered across the Euro-zone. The company's R&D team will double in size, allowing Telemis Group to continue to develop market-leading products and services across a wide range of disciplines, including Telecardiology and Telemedicine.

Under the terms of the Telemis acquisition, ITZ Medicom becomes an integral part of the Telemis Group and Lothar Hoheisel, the prior owner and managing director of ITZ Medicom, will assume the new role of general manager for Telemis in Germany. Under the Telemis brand, they will continue to support over 500 German customers, with a seamless transition.

Commenting on the acquisition, Stephane Ketelaer, CEO of the Telemis Group said: "Telemis is a strong company, with a record of continuous profitability over 17 years. The acquisition of ITZ Medicom will allow us to address the important German market with a strong team of people that understand the local customer base and its needs. The combined product portfolio will benefit from ITZ Medicom's strength in Telemedicine and Telecardiology and the acquisition delivers a significantly enhanced R&D team that will drive the product portfolio forward. The future for the Telemis Group has never looked better."

Lothar Hoheisel, Managing Director of ITZ Medicom added: "We are very excited to become part of the Telemis Group. We will continue to service our existing customers in Germany and look forward to welcoming many new customers. The size and scale of the Telemis Group will allow us to rapidly increase the products and services we are able to offer - this is a good move for the ITZ Medicom team and its customers."

About Telemis

Telemis specialises in the development of medical imaging software and more specifically MACS (Multimedia Archiving and Communication System) software. The Telemis product line aims to assist hospitals, clinics and private practices to manage digital medical images and to increase the quality of the care provided.

Created in 1999 as a start-up from advanced university research, Telemis is located on the campus of the Université catholique de Louvain (UCL) in Louvain-La-Neuve, Belgium with international offices in Luxembourg, Toulouse, Turin and Neuchâtel. It shares and collaborates with UCL and other top notch university centers on technology development and, as a leading provider of integrated medical imaging IT solutions, has equipped 278 hospitals and other healthcare centres with its products across Europe, Middle East and Africa.

For more information on Telemis, TM-MACS, TM-Microscopy and INTUITUS, go to:

www.telemis.com
macs.telemis.com

microscopy.telemis.com

www.intuitus-cockpit.com

Photo - https://mma.prnewswire.com/media/1027603/Telemis.jpg

Contact Details:

Europe:
Telephone: +32-10-48-00-11
Email: info@telemis.com

North America:
Telephone: +1 703 436 9376
Email: info@telemis.com

© 2019 PR Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.